Bushra Ijaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bushra Ijaz has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Sidra Rehman
Department of Biosciences, COMSATS University Islamabad (CUI), Park Road, Islamabad, 45550, Pakistan
4 shared publications Ayesha Malik
Centre of Excellence in Molecular Biology, University of the Punjab, 87 West Canal Road, Thokar Niaz Baig, Lahore, Pakistan
3 shared publications- Imran Shahid
Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
3 shared publications - Sobia Noreen
Institute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan
3 shared publications - Usman Ali Ashfaq
Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan
3 shared publications - Ayesha Malik
Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
2 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Wiley in New Phytologist
Mutations in SUMO conjugating enzyme reveal contributions of sumoylation to plant stress resilience and yield
Summary: Small ubiquitin‐related modifier (SUMO) conjugation is a fundamental process in all metazoa, with multiple roles in development and stress responses. In Arabidopsis thaliana and many other dicots, the SUMO conjugating enzyme (SCE) is a single‐copy gene, making it a linchpin in all transcriptional and posttranscriptional processes influenced by sumoylation. Loss of function of Arabidopsis SCE1 is lethal, but we were able to generate a hypomorphic (decrease‐of‐function; sce1‐100 ) and a hypermorphic (increase‐of‐function; SCE1 K28R) allele of this gene. The hypomorphic allele has traits in common with a mutant defective in SUMO ligase SIZ1, compromising development and stress resilience. We compare transcriptional responses of sce1‐100 and siz1 and define processes that depend on SUMO but are independent of salicylic acid, a plant hormone that accumulates upon a decrease in sumoylation. The hypermorphic allele SCE1 K28R impacts on plants under normal glasshouse conditions, leading to higher seed yield. Under the stress of low nitrogen supply, these plants show increased root foraging, facilitating nitrogen uptake under limiting conditions. The two SCE1 mutant alleles provide a valuable framework for uncovering processes with SUMO participation. Due to their NGT1 (non‐transgenic) legal status, experiments outside transgene confinement facilities will be possible with these mutants.
- 25 September 2026
- Published by Wiley in New Phytologist
Open AccessMutations in SUMO conjugating enzyme reveal contributions of sumoylation to plant stress resilience and yield
Summary: Small ubiquitin‐related modifier (SUMO) conjugation is a fundamental process in all metazoa, with multiple roles in development and stress responses. In Arabidopsis thaliana and many other dicots, the SUMO conjugating enzyme (SCE) is a single‐copy gene, making it a linchpin in all transcriptional and posttranscriptional processes influenced by sumoylation. Loss of function of Arabidopsis SCE1 is lethal, but we were able to generate a hypomorphic (decrease‐of‐function; sce1‐100 ) and a hypermorphic (increase‐of‐function; SCE1 K28R) allele of this gene. The hypomorphic allele has traits in common with a mutant defective in SUMO ligase SIZ1, compromising development and stress resilience. We compare transcriptional responses of sce1‐100 and siz1 and define processes that depend on SUMO but are independent of salicylic acid, a plant hormone that accumulates upon a decrease in sumoylation. The hypermorphic allele SCE1 K28R impacts on plants under normal glasshouse conditions, leading to higher seed yield. Under the stress of low nitrogen supply, these plants show increased root foraging, facilitating nitrogen uptake under limiting conditions. The two SCE1 mutant alleles provide a valuable framework for uncovering processes with SUMO participation. Due to their NGT1 (non‐transgenic) legal status, experiments outside transgene confinement facilities will be possible with these mutants.
- 12 February 2026
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 26 (01) , 1-33
Design, Synthesis, In vitro , Molecular Docking and Simulation Assessment of Benzimidazole Derivatives Against Liver Cancer by Targeting STAT3, Bcl2 and MDM2
Hepatocellular carcinoma (HCC) is the most common primary liver cancer type and continues to be a significant global health problem because of late diagnosis and inadequate treatment response. In this study, a novel benzimidazole-based chalcone series was synthesized and tested for its anticancer activity on the liver HepG-2 cancer cell line. Compounds were prepared in a DMSO solution and screened for cytotoxicity using the MTT assay. Among them, 4e exhibited the strongest cytotoxicity (IC50 [ ] 6.68 ± 0.08 [ ]M), markedly inhibiting cell proliferation and migration, while showing no toxicity against human kidney cells HEK293. A wound healing (scratch) assay showed that cell migration was reduced upon treatment, indicating anti-metastatic activity. RT-qPCR analysis revealed significant downregulation of the key oncogenes Bcl2, STAT3 and MDM2, showing pro-apoptotic and anti-proliferative effects. Additionally, PASS predictions showed similar anticancer probabilities (Pa [ ] 0.5). Molecular docking studies demonstrated that cancer-related proteins had strong binding affinities to the compounds, forming stable ligand–protein complexes as confirmed by 100 ns molecular dynamics simulations using Desmond. Under physiological conditions, the ligand–protein complexes remained intact throughout the entire simulation, confirming the stability of the interactions. This integrative approach, which combines synthetic chemistry, in vitro testing, gene expression analysis and computational modeling, emphasizes the therapeutic potential of 4e as a promising benzimidazole derivative for future preclinical development against HCC.
- 12 February 2026
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 26 (01) , 1-33
Design, Synthesis, In vitro , Molecular Docking and Simulation Assessment of Benzimidazole Derivatives Against Liver Cancer by Targeting STAT3, Bcl2 and MDM2
Hepatocellular carcinoma (HCC) is the most common primary liver cancer type and continues to be a significant global health problem because of late diagnosis and inadequate treatment response. In this study, a novel benzimidazole-based chalcone series was synthesized and tested for its anticancer activity on the liver HepG-2 cancer cell line. Compounds were prepared in a DMSO solution and screened for cytotoxicity using the MTT assay. Among them, 4e exhibited the strongest cytotoxicity (IC50 [ ] 6.68 ± 0.08 [ ]M), markedly inhibiting cell proliferation and migration, while showing no toxicity against human kidney cells HEK293. A wound healing (scratch) assay showed that cell migration was reduced upon treatment, indicating anti-metastatic activity. RT-qPCR analysis revealed significant downregulation of the key oncogenes Bcl2, STAT3 and MDM2, showing pro-apoptotic and anti-proliferative effects. Additionally, PASS predictions showed similar anticancer probabilities (Pa [ ] 0.5). Molecular docking studies demonstrated that cancer-related proteins had strong binding affinities to the compounds, forming stable ligand–protein complexes as confirmed by 100 ns molecular dynamics simulations using Desmond. Under physiological conditions, the ligand–protein complexes remained intact throughout the entire simulation, confirming the stability of the interactions. This integrative approach, which combines synthetic chemistry, in vitro testing, gene expression analysis and computational modeling, emphasizes the therapeutic potential of 4e as a promising benzimidazole derivative for future preclinical development against HCC.
- Top Cited Papers
- 13 January 2026
- Published by Elsevier in Drug Resistance Updates
- Vol. 85, 101355
The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy
- 13 January 2026
- Published by Elsevier in Drug Resistance Updates
- Vol. 85, 101355
Top Cited PapersThe hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy
- 11 January 2025
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 407, 111384
Antifibrotic potential of reserpine (alkaloid) targeting Keap1/Nrf2; oxidative stress pathway in CCl4-induced liver fibrosis
- 11 January 2025
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 407, 111384
Antifibrotic potential of reserpine (alkaloid) targeting Keap1/Nrf2; oxidative stress pathway in CCl4-induced liver fibrosis
- 29 August 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 195, 106894
Exploring antiviral activity of Betanin and Glycine Betaine against dengue virus type-2 in transfected Hela cells
- 29 August 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 195, 106894
Exploring antiviral activity of Betanin and Glycine Betaine against dengue virus type-2 in transfected Hela cells
- 30 July 2024
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 24 (4) , 1-23
CRISPR-Cas9 mediated understanding of plants’ abiotic stress-responsive genes to combat changing climatic patterns
Multiple abiotic stresses like extreme temperatures, water shortage, flooding, salinity, and exposure to heavy metals are confronted by crop plants with changing climatic patterns. Prolonged exposure to these adverse environmental conditions leads to stunted plant growth and development with significant yield loss in crops. CRISPR-Cas9 genome editing tool is being frequently employed to understand abiotic stress-responsive genes. Noteworthy improvements in CRISPR-Cas technology have been made over the years, including upgradation of Cas proteins fidelity and efficiency, optimization of transformation protocols for different crop species, base and prime editing, multiplex gene-targeting, transgene-free editing, and graft-based heritable CRISPR-Cas9 approaches. These developments helped to improve the knowledge of abiotic stress tolerance in crops that could potentially be utilized to develop knock-out varieties and over-expressed lines to tackle the adverse effects of altered climatic patterns. This review summarizes the mechanistic understanding of heat, drought, salinity, and metal stress-responsive genes characterized so far using CRISPR-Cas9 and provides data on potential candidate genes that can be exploited by modern-day biotechnological tools to develop transgene-free genome-edited crops with better climate adaptability. Furthermore, the importance of early-maturing crop varieties to withstand abiotic stresses is also discussed in this review.
- 30 July 2024
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 24 (4) , 1-23
CRISPR-Cas9 mediated understanding of plants’ abiotic stress-responsive genes to combat changing climatic patterns
Multiple abiotic stresses like extreme temperatures, water shortage, flooding, salinity, and exposure to heavy metals are confronted by crop plants with changing climatic patterns. Prolonged exposure to these adverse environmental conditions leads to stunted plant growth and development with significant yield loss in crops. CRISPR-Cas9 genome editing tool is being frequently employed to understand abiotic stress-responsive genes. Noteworthy improvements in CRISPR-Cas technology have been made over the years, including upgradation of Cas proteins fidelity and efficiency, optimization of transformation protocols for different crop species, base and prime editing, multiplex gene-targeting, transgene-free editing, and graft-based heritable CRISPR-Cas9 approaches. These developments helped to improve the knowledge of abiotic stress tolerance in crops that could potentially be utilized to develop knock-out varieties and over-expressed lines to tackle the adverse effects of altered climatic patterns. This review summarizes the mechanistic understanding of heat, drought, salinity, and metal stress-responsive genes characterized so far using CRISPR-Cas9 and provides data on potential candidate genes that can be exploited by modern-day biotechnological tools to develop transgene-free genome-edited crops with better climate adaptability. Furthermore, the importance of early-maturing crop varieties to withstand abiotic stresses is also discussed in this review.
- 18 December 2023
- Published by Springer Nature in Biochemical Genetics
- Vol. 62 (5) , 3421-3438
LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway Modulation
Breast cancer is a significant health challenge for women globally, including the Pakistani population. Numerous pathways and small molecules like noncoding ribonucleotides are implicated in breast cancer development and progression. Among these, lncRNAs, have garnered considerable attention due to their role in breast cancer tumorigenesis and metastasis. In the current study involving 52 mammary tumor samples from the Pakistani population, the expression of lncRNA MALAT1 (metastasis associated lung adenocarcinoma transcript 1) was studied via RT-PCR (Real-Time polymerase chain reaction). In addition, PI3K/AKT/mTOR pathway expression was also assessed through RT-PCR and immunohistochemistry in breast cancer patient samples. The study also investigated the cross-talk of lncRNA MALAT1 and PI3K pathway genes by inhibiting it with PI3K inhibitor (LY294002) in MDA-MB-231 cell line. Furthermore, lncRNA MALAT1 was silenced in MDA-MB-231 cells using siRNA to determine its impact on breast cancer proliferation and metastasis. The results revealed an upregulated expression of MALAT1 and PI3K/AKT/mTOR pathway genes in grade II and III breast tissue samples before chemotherapy. The proliferation, growth, and invasion of breast cancer cells were significantly reduced upon MALAT1 silencing in MDA-MB-231. Further, its downregulation substantially reduced the PI3K pathway expression levels at mRNA and protein levels. In conclusion, the current study suggests that MALAT1 could serve as a therapeutic target for breast cancer, underscoring its role in breast cancer proliferation and metastasis. Moreover, the study proposes a mechanism of action of MALAT1, demonstrating that its inhibition can reduce the expression of the PI3K/AKT/mTOR axis. These findings emphasize the potential significance of targeting MALAT1 as a therapeutic strategy for breast cancer, and further exploration of this interaction is warranted to gain deeper insight into the molecular mechanism of this lncRNA.
- 18 December 2023
- Published by Springer Nature in Biochemical Genetics
- Vol. 62 (5) , 3421-3438
LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway Modulation
Breast cancer is a significant health challenge for women globally, including the Pakistani population. Numerous pathways and small molecules like noncoding ribonucleotides are implicated in breast cancer development and progression. Among these, lncRNAs, have garnered considerable attention due to their role in breast cancer tumorigenesis and metastasis. In the current study involving 52 mammary tumor samples from the Pakistani population, the expression of lncRNA MALAT1 (metastasis associated lung adenocarcinoma transcript 1) was studied via RT-PCR (Real-Time polymerase chain reaction). In addition, PI3K/AKT/mTOR pathway expression was also assessed through RT-PCR and immunohistochemistry in breast cancer patient samples. The study also investigated the cross-talk of lncRNA MALAT1 and PI3K pathway genes by inhibiting it with PI3K inhibitor (LY294002) in MDA-MB-231 cell line. Furthermore, lncRNA MALAT1 was silenced in MDA-MB-231 cells using siRNA to determine its impact on breast cancer proliferation and metastasis. The results revealed an upregulated expression of MALAT1 and PI3K/AKT/mTOR pathway genes in grade II and III breast tissue samples before chemotherapy. The proliferation, growth, and invasion of breast cancer cells were significantly reduced upon MALAT1 silencing in MDA-MB-231. Further, its downregulation substantially reduced the PI3K pathway expression levels at mRNA and protein levels. In conclusion, the current study suggests that MALAT1 could serve as a therapeutic target for breast cancer, underscoring its role in breast cancer proliferation and metastasis. Moreover, the study proposes a mechanism of action of MALAT1, demonstrating that its inhibition can reduce the expression of the PI3K/AKT/mTOR axis. These findings emphasize the potential significance of targeting MALAT1 as a therapeutic strategy for breast cancer, and further exploration of this interaction is warranted to gain deeper insight into the molecular mechanism of this lncRNA.
- Open Access
- 1 December 2023
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 16 (12) , 105323
Evaluation of betanin-encapsulated biopolymeric nanoparticles for antitumor activity via PI3K/Akt/mTOR signaling pathway
- 1 December 2023
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 16 (12) , 105323
Open AccessEvaluation of betanin-encapsulated biopolymeric nanoparticles for antitumor activity via PI3K/Akt/mTOR signaling pathway
- Open Access
- 26 September 2023
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 88, 105001
Polymeric complex nanocarriers of Mangifera indica gum & chitosan for methotrexate delivery: Formulation, characterization, and in vitro toxicological assessment
- 26 September 2023
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 88, 105001
Open AccessPolymeric complex nanocarriers of Mangifera indica gum & chitosan for methotrexate delivery: Formulation, characterization, and in vitro toxicological assessment